U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

ALOE VERA WHOLE

MORE DETAILS

KIZ4X2EHYX

structurally diverse
Status:
Possibly Marketed Outside US
Source:
NCT03355846: Phase 4 Interventional Completed Acute Anal Fissure
(2018)
Source URL:
https://clinicaltrials.gov/ct2/show/NCT03355846
First approved in 1995
Source:
21 CFR 348
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=489c554f-efd8-4606-8d17-82c1d58ae08b
Class:
STRUCTURALLY DIVERSE
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966